[Federal Register Volume 69, Number 133 (Tuesday, July 13, 2004)]
[Notices]
[Page 42068]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-15772]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 29, 2004, Eli-Elsohly 
Laboratories, Inc., Mahmoud A. Elsohly Ph.D., 5 Industrial Park Drive, 
Oxford, Mississippi 38655, made application by renewal to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below.

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the controlled substances for use in 
analysis and drug test standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than September 
13, 2004.

    Dated: June 28, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-15772 Filed 7-12-04; 8:45 am]
BILLING CODE 4410-09-M